(MTX) MTU Aero Engines - Overview
Sector: IndustrialsIndustry: Aerospace & Defense | Exchange XETRA (Germany) | Currency EUR | Market Cap: 18.439m | Total Return -6.7% in 12m
Stock: Aircraft Engines, Industrial Turbines, Engine Maintenance, Spare Parts
Total Rating 44
Risk 64
Buy Signal -1.49
| Risk 5d forecast | |
|---|---|
| Volatility | 45.7% |
| Relative Tail Risk | -2.04% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.20 |
| Alpha | -19.20 |
| Character TTM | |
|---|---|
| Beta | 0.760 |
| Beta Downside | 0.685 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.13% |
| CAGR/Max DD | 0.28 |
EPS (Earnings per Share)
Revenue
Description: MTX MTU Aero Engines March 04, 2026
MTU Aero Engines AG (MTX) develops, manufactures, markets, and maintains aircraft engines and industrial gas turbines globally. The company operates in two segments: Original Equipment Manufacturing (OEM) and Maintenance, Repair, and Overhaul (MRO).
The OEM segment produces engines for various aircraft types, including commercial wide-body, narrow-body, regional jets, business jets, and military fighter jets and helicopters. Aircraft engine manufacturing is a capital-intensive industry with long product lifecycles.
The MRO segment provides maintenance, repair, and overhaul services for commercial and military engines, and sells spare parts. The MRO market is characterized by high barriers to entry due to stringent regulatory requirements and specialized technical expertise. Investors can find further detailed analysis of MTXs operational performance on ValueRay.
Headlines to watch out for
- Commercial aircraft engine demand drives OEM segment revenue
- Military engine contracts secure long-term revenue streams
- Maintenance, Repair, and Overhaul (MRO) backlog ensures stable income
- Global air travel recovery boosts MRO and spare parts sales
- Supply chain disruptions impact production and cost efficiency
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 1.65b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 2.42 > 1.0 |
| NWC/Revenue: 12.87% < 20% (prev 16.25%; Δ -3.38% < -1%) |
| CFO/TA 0.07 > 3% & CFO 848.0m > Net Income 1.65b |
| Net Debt (2.45b) to EBITDA (2.40b): 1.02 < 3 |
| Current Ratio: 1.39 > 1.5 & < 3 |
| Outstanding Shares: last quarter (54.1m) vs 12m ago 0.08% < -2% |
| Gross Margin: 19.02% > 18% (prev 0.08%; Δ 1.89k% > 0.5%) |
| Asset Turnover: 126.1% > 50% (prev 77.95%; Δ 48.12% > 0%) |
| Interest Coverage Ratio: 8.52 > 6 (EBITDA TTM 2.40b / Interest Expense TTM 164.0m) |
Altman Z'' 2.78
| A: 0.16 (Total Current Assets 6.79b - Total Current Liabilities 4.88b) / Total Assets 11.78b |
| B: 0.28 (Retained Earnings 3.32b / Total Assets 11.78b) |
| C: 0.12 (EBIT TTM 1.40b / Avg Total Assets 11.80b) |
| D: 0.0 (Book Value of Equity 0.0 / Total Liabilities 7.87b) |
| Altman-Z'' Score: 2.78 = A |
Beneish M
| DSRI: none (Receivables none/3.55b, Revenue 14.87b/9.21b) |
| GMI: 0.44 (GM 19.02% / 8.39%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.62 (Revenue 14.87b / 9.21b) |
| TATA: 0.07 (NI 1.65b - CFO 848.0m) / TA 11.78b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of MTX shares?
As of March 30, 2026, the stock is trading at EUR 296.90 with a total of 190,802 shares traded.
Over the past week, the price has changed by -4.60%, over one month by -18.75%, over three months by -15.99% and over the past year by -6.68%.
Over the past week, the price has changed by -4.60%, over one month by -18.75%, over three months by -15.99% and over the past year by -6.68%.
Is MTX a buy, sell or hold?
MTU Aero Engines has no consensus analysts rating.
What are the forecasts/targets for the MTX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 419.2 | 41.2% |
| Analysts Target Price | - | - |
MTX Fundamental Data Overview March 29, 2026
Market Cap USD = 18.44b (15.98b EUR * 1.1537 EUR.USD)
P/E Trailing = 15.7173
P/E Forward = 16.5563
P/S = 1.8239
P/B = 3.768
P/EG = 1.0609
Revenue TTM = 14.87b EUR
EBIT TTM = 1.40b EUR
EBITDA TTM = 2.40b EUR
Long Term Debt = 1.97b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 288.0m EUR (from shortTermDebt, two quarters ago)
Debt = 2.45b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 2.45b EUR (using Total Debt 2.45b, CCE unavailable)
Enterprise Value = 18.43b EUR (15.98b + Debt 2.45b - (null CCE))
Interest Coverage Ratio = 8.52 (Ebit TTM 1.40b / Interest Expense TTM 164.0m)
EV/FCF = 36.57x (Enterprise Value 18.43b / FCF TTM 504.0m)
FCF Yield = 2.73% (FCF TTM 504.0m / Enterprise Value 18.43b)
FCF Margin = 3.39% (FCF TTM 504.0m / Revenue TTM 14.87b)
Net Margin = 11.12% (Net Income TTM 1.65b / Revenue TTM 14.87b)
Gross Margin = 19.02% ((Revenue TTM 14.87b - Cost of Revenue TTM 12.04b) / Revenue TTM)
Gross Margin QoQ = 18.83% (prev 22.39%)
Tobins Q-Ratio = 1.56 (Enterprise Value 18.43b / Total Assets 11.78b)
Interest Expense / Debt = 1.84% (Interest Expense 45.0m / Debt 2.45b)
Taxrate = 19.41% (124.0m / 639.0m)
NOPAT = 1.13b (EBIT 1.40b * (1 - 19.41%))
Current Ratio = 1.39 (Total Current Assets 6.79b / Total Current Liabilities 4.88b)
Debt / Equity = 0.64 (Debt 2.45b / totalStockholderEquity, two quarters ago 3.84b)
Debt / EBITDA = 1.02 (Net Debt 2.45b / EBITDA 2.40b)
Debt / FCF = 4.86 (Net Debt 2.45b / FCF TTM 504.0m)
Total Stockholder Equity = 3.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.02% (Net Income 1.65b / Total Assets 11.78b)
RoE = 46.43% (Net Income TTM 1.65b / Total Stockholder Equity 3.56b)
RoCE = 25.26% (EBIT 1.40b / Capital Employed (Equity 3.56b + L.T.Debt 1.97b))
RoIC = 20.25% (NOPAT 1.13b / Invested Capital 5.56b)
WACC = 7.71% (E(15.98b)/V(18.43b) * Re(8.66%) + D(2.45b)/V(18.43b) * Rd(1.84%) * (1-Tc(0.19)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.35%
[DCF] Terminal Value 80.68% ; FCFF base≈390.4m ; Y1≈424.2m ; Y5≈531.4m
[DCF] Fair Price = 139.3 (EV 9.95b - Net Debt 2.45b = Equity 7.50b / Shares 53.8m; r=7.71% [WACC]; 5y FCF grow 9.84% → 3.0% )
EPS Correlation: 92.66 | EPS CAGR: 29.44% | SUE: -0.69 | # QB: 0
Revenue Correlation: 44.55 | Revenue CAGR: 21.73% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.63 | Chg7d=+4.630 | Chg30d=+4.630 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=19.00 | Chg7d=-0.058 | Chg30d=+0.088 | Revisions Net=+0 | Growth EPS=+6.8% | Growth Revenue=+9.8%
EPS next Year (2027-12-31): EPS=20.87 | Chg7d=-0.045 | Chg30d=+0.057 | Revisions Net=+4 | Growth EPS=+9.8% | Growth Revenue=+10.2%
[Analyst] Revisions Ratio: +0.00 (6 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 8.7% - Earnings Yield 6.4%)
[Growth] Growth Spread = +7.8% (Analyst 10.1% - Implied 2.3%)
P/E Trailing = 15.7173
P/E Forward = 16.5563
P/S = 1.8239
P/B = 3.768
P/EG = 1.0609
Revenue TTM = 14.87b EUR
EBIT TTM = 1.40b EUR
EBITDA TTM = 2.40b EUR
Long Term Debt = 1.97b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 288.0m EUR (from shortTermDebt, two quarters ago)
Debt = 2.45b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 2.45b EUR (using Total Debt 2.45b, CCE unavailable)
Enterprise Value = 18.43b EUR (15.98b + Debt 2.45b - (null CCE))
Interest Coverage Ratio = 8.52 (Ebit TTM 1.40b / Interest Expense TTM 164.0m)
EV/FCF = 36.57x (Enterprise Value 18.43b / FCF TTM 504.0m)
FCF Yield = 2.73% (FCF TTM 504.0m / Enterprise Value 18.43b)
FCF Margin = 3.39% (FCF TTM 504.0m / Revenue TTM 14.87b)
Net Margin = 11.12% (Net Income TTM 1.65b / Revenue TTM 14.87b)
Gross Margin = 19.02% ((Revenue TTM 14.87b - Cost of Revenue TTM 12.04b) / Revenue TTM)
Gross Margin QoQ = 18.83% (prev 22.39%)
Tobins Q-Ratio = 1.56 (Enterprise Value 18.43b / Total Assets 11.78b)
Interest Expense / Debt = 1.84% (Interest Expense 45.0m / Debt 2.45b)
Taxrate = 19.41% (124.0m / 639.0m)
NOPAT = 1.13b (EBIT 1.40b * (1 - 19.41%))
Current Ratio = 1.39 (Total Current Assets 6.79b / Total Current Liabilities 4.88b)
Debt / Equity = 0.64 (Debt 2.45b / totalStockholderEquity, two quarters ago 3.84b)
Debt / EBITDA = 1.02 (Net Debt 2.45b / EBITDA 2.40b)
Debt / FCF = 4.86 (Net Debt 2.45b / FCF TTM 504.0m)
Total Stockholder Equity = 3.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.02% (Net Income 1.65b / Total Assets 11.78b)
RoE = 46.43% (Net Income TTM 1.65b / Total Stockholder Equity 3.56b)
RoCE = 25.26% (EBIT 1.40b / Capital Employed (Equity 3.56b + L.T.Debt 1.97b))
RoIC = 20.25% (NOPAT 1.13b / Invested Capital 5.56b)
WACC = 7.71% (E(15.98b)/V(18.43b) * Re(8.66%) + D(2.45b)/V(18.43b) * Rd(1.84%) * (1-Tc(0.19)))
Discount Rate = 8.66% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.35%
[DCF] Terminal Value 80.68% ; FCFF base≈390.4m ; Y1≈424.2m ; Y5≈531.4m
[DCF] Fair Price = 139.3 (EV 9.95b - Net Debt 2.45b = Equity 7.50b / Shares 53.8m; r=7.71% [WACC]; 5y FCF grow 9.84% → 3.0% )
EPS Correlation: 92.66 | EPS CAGR: 29.44% | SUE: -0.69 | # QB: 0
Revenue Correlation: 44.55 | Revenue CAGR: 21.73% | SUE: 0.10 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.63 | Chg7d=+4.630 | Chg30d=+4.630 | Revisions Net=+0 | Analysts=1
EPS current Year (2026-12-31): EPS=19.00 | Chg7d=-0.058 | Chg30d=+0.088 | Revisions Net=+0 | Growth EPS=+6.8% | Growth Revenue=+9.8%
EPS next Year (2027-12-31): EPS=20.87 | Chg7d=-0.045 | Chg30d=+0.057 | Revisions Net=+4 | Growth EPS=+9.8% | Growth Revenue=+10.2%
[Analyst] Revisions Ratio: +0.00 (6 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 8.7% - Earnings Yield 6.4%)
[Growth] Growth Spread = +7.8% (Analyst 10.1% - Implied 2.3%)